C15:0 and Women’s Health: The Saturated Fat That Is Changing the Conversation About Heart, Hormone, and Cellular Health

Medically reviewed and written by Dr. Cindy Grow, APRN
Founder of My Venus Club™
Updated April 2026

Introduction: What If Saturated Fat Is More Complicated Than We Were Told?

For decades, women were told to avoid saturated fat.

We were told to choose low-fat yogurt, skim milk, fat-free products, and to believe that full-fat dairy was automatically harmful. Butter was blamed. Whole milk was avoided. Saturated fat became one large category, and women were rarely taught that different fatty acids can behave very differently inside the body.

But nutrition science is more nuanced than that.

One saturated fatty acid in particular is changing the conversation. It is called pentadecanoic acid, also known as C15:0. It is a rare odd-chain saturated fatty acid found naturally in small amounts in whole-fat dairy, butter, cheese, yogurt, some fish, and ruminant fats.

Emerging research suggests that C15:0 may play a role in cellular health, cardiometabolic resilience, inflammation, liver health, and biological aging pathways. This does not mean C15:0 is a cure-all. It does not mean every woman should eat unlimited saturated fat. It does not mean C15:0 reverses aging or replaces medical care.

What it does mean is that the old message, “all saturated fat is bad,” is too simplistic.

At My Venus Club™, we do not follow nutrition dogma. We follow the science, and we apply that science with precision, context, and clinical judgment.

What Is C15:0?

C15:0 is the shorthand name for pentadecanoic acid, a saturated fatty acid with 15 carbon atoms. Because it has an odd number of carbon atoms, it is classified as an odd-chain saturated fatty acid.

That structure matters. Fatty acids are not interchangeable. Their chain length, saturation, and structure influence how they behave in cell membranes, metabolic pathways, inflammatory signaling, and energy regulation.

For many years, C15:0 was mainly viewed as a biomarker of dairy fat intake. Researchers used it as a clue that someone was consuming dairy fat. Over time, however, studies began showing something more interesting: higher circulating levels of odd-chain saturated fatty acids, including C15:0, were often associated with more favorable metabolic and cardiovascular patterns.

That observation led scientists to ask a deeper question.

What if C15:0 is not just a marker of certain foods?

What if it has biological activity of its own?

Why C15:0 Is Different From Other Saturated Fats

Not all saturated fats behave the same way.

Palmitic acid, also known as C16:0, is a common even-chain saturated fat that can be associated with inflammation, insulin resistance, and unfavorable lipid patterns when present in excess or produced through metabolic dysfunction.

Stearic acid, also known as C18:0, is another even-chain saturated fat. It is found in foods such as cocoa butter, beef, and dark chocolate and is generally considered more neutral for cholesterol compared with some other saturated fats.

Lauric acid and myristic acid, found in coconut oil and dairy, can raise HDL cholesterol but may also raise LDL cholesterol.

C15:0 appears different because it is an odd-chain fatty acid. Its structure may influence cellular signaling, inflammation, and metabolism in ways that are distinct from more common saturated fats.

This is why the conversation should not be “saturated fat is good” or “saturated fat is bad.” The better conversation is more precise: which saturated fat, from what food source, in what metabolic context, for which woman, and with what cardiometabolic risk profile?

The Research Story: Dr. Stephanie Venn-Watson and C15:0

Much of the modern interest in C15:0 comes from the work of Dr. Stephanie Venn-Watson, a veterinary epidemiologist and public health scientist whose research included studying long-lived dolphins in the U.S. Navy Marine Mammal Program.

The origin story is unusual, but it became scientifically important. Researchers studying dolphins noticed metabolic patterns that led them to investigate odd-chain fatty acids, especially C15:0. That work eventually contributed to a larger scientific question: could C15:0 be more than a passive marker of dairy fat intake?

In 2020, Dr. Venn-Watson and colleagues published a paper in Scientific Reports discussing dietary odd-chain saturated fatty acids and the possibility that C15:0 may be essential or conditionally essential. The paper reviewed evidence connecting higher circulating C15:0 and C17:0 levels with lower cardiometabolic disease risk and explored whether declining population levels of odd-chain fatty acids could matter for long-term health.

Later, Venn-Watson and collaborators published cell-based research comparing pure C15:0 with EPA and other compounds across human cell systems. Additional research explored C15:0 in relation to longevity-associated pathways, including AMPK activation and mTOR inhibition.

This research is important because it helped move C15:0 from a little-known dairy-fat biomarker into a broader conversation about cellular health, metabolic resilience, and healthy aging.

It is also important to be transparent. Dr. Venn-Watson has been involved in the commercialization of C15:0 through companies associated with Fatty15. That does not invalidate the research, but it does mean the science should be interpreted carefully, with attention to study design, independent replication, human clinical outcomes, and potential conflicts of interest.

A responsible review of C15:0 should do both things at once: acknowledge the significance of her research and avoid overstating what has been proven.

What the Research Suggests So Far

The current C15:0 research is promising, but it is still developing.

Observational studies have associated higher circulating levels of C15:0 with more favorable cardiometabolic outcomes. These include patterns related to lower risk of type 2 diabetes, metabolic dysfunction, cardiovascular disease, and liver-related concerns.

Cell-based and preclinical studies suggest that C15:0 may influence pathways involved in inflammation, mitochondrial function, nutrient sensing, lipid metabolism, and cellular resilience.

Some research suggests C15:0 may affect AMPK, PPAR, Nrf2, NF-kB, and mTOR-related signaling. These pathways matter because they are involved in energy sensing, fat metabolism, antioxidant defense, inflammation, cellular growth signaling, and aging biology.

However, pathway activity is not the same as proven clinical benefit. A nutrient can look promising in cells and animals but still require stronger human trials before clinicians can make confident claims.

That is why C15:0 should be discussed as a promising nutrient, not a guaranteed anti-aging therapy.

What C15:0 Does Not Prove

C15:0 is not a magic bullet.

The research does not prove that C15:0 reverses aging by itself, prevents heart disease, replaces exercise, replaces hormone evaluation, treats menopause, cures inflammation, or works equally well for every woman.

The current evidence is strongest for association, biological plausibility, and early mechanistic research. Human supplementation studies are emerging, but we still need larger, longer, and more diverse clinical trials, especially in women, perimenopausal women, postmenopausal women, and women with different metabolic and cardiovascular profiles.

This distinction matters because women deserve honest information, not another wellness trend wrapped in scientific language.

Why C15:0 May Matter for Women in Perimenopause

Perimenopause is not only a hormonal transition. It is also a metabolic, inflammatory, vascular, mitochondrial, and cellular transition.

During perimenopause, many women experience changes in estrogen, progesterone, cortisol sensitivity, insulin sensitivity, sleep quality, body composition, inflammation, lipid patterns, and stress resilience.

These changes can feel sudden, but they are often connected. A woman may notice that her waistline changes, sleep becomes lighter, energy feels less predictable, recovery slows, cravings increase, and the same routine no longer produces the same results.

This is exactly the season of life when cellular health becomes more important.

If C15:0 supports cellular signaling, inflammatory balance, mitochondrial function, and metabolic flexibility, it may be relevant for some women navigating this transition. But it should always be evaluated in context.

The question is not, “Should every woman take C15:0?”

The better question is, “Does this woman have a pattern where C15:0 may be useful as part of a larger health strategy?”

C15:0 and Cellular Health

Cellular health is the foundation of energy, metabolism, immune balance, hormone communication, and healthy aging.

Your cells need healthy membranes, functioning mitochondria, balanced inflammatory signaling, efficient nutrient sensing, and the ability to repair damage. When cellular health is strong, the body is more resilient. When cellular health becomes fragile, women may notice fatigue, poor recovery, weight resistance, brain fog, inflammation, low motivation, and reduced stress tolerance.

C15:0 is interesting because researchers are exploring whether it acts not only as a fat but also as a cellular signal. In cell-based research, C15:0 has been studied in relation to pathways that influence inflammation, energy sensing, metabolic flexibility, and mitochondrial function.

This is why I discuss C15:0 as part of the cellular health conversation. It should not be framed as a quick fix. It should be framed as one possible tool within a broader strategy to support cellular resilience.

C15:0 and Cardiometabolic Health

C15:0 has gained attention because higher circulating levels have been associated with more favorable cardiometabolic patterns in several observational studies.

This matters because cardiometabolic risk often rises in midlife women. Estrogen changes, poor sleep, chronic stress, abdominal weight gain, insulin resistance, inflammation, and family history can all change a woman’s risk profile.

A nutrient that may support metabolic signaling, lipid behavior, inflammation, and cellular resilience is worth studying. But association does not prove causation. Higher C15:0 levels may reflect dairy intake, other dietary patterns, metabolic differences, gut microbial activity, or other health behaviors.

That is why I would never say, “Take C15:0 and your heart risk is handled.”

A more responsible approach is to evaluate cardiometabolic risk deeply. That means looking at insulin, glucose, triglycerides, ApoB or LDL particle patterns, inflammation markers, fatty acid balance, blood pressure, sleep, stress, hormones, family history, and lifestyle.

If C15:0 fits into that picture, it can be considered thoughtfully.

C15:0 and Liver Health

The liver is central to metabolism, detoxification, hormone processing, lipid regulation, blood sugar balance, and inflammatory control.

Some C15:0 research has explored links with liver health and metabolic dysfunction-associated fatty liver risk. This is especially relevant for women because fatty liver risk can increase with insulin resistance, visceral fat, perimenopause, poor sleep, alcohol intake, ultra-processed foods, and chronic inflammation.

If C15:0 supports metabolic and inflammatory pathways, it may become part of future liver-health conversations. For now, it should not be positioned as a treatment for fatty liver disease.

Liver health still begins with blood sugar regulation, strength training, nutrition, sleep, alcohol awareness, gut health, and medical evaluation when liver enzymes or imaging are abnormal.

C15:0, Epigenetics, and Healthy Aging

Your genes are not your destiny. Lifestyle, nutrition, stress, inflammation, sleep, movement, hormones, toxins, and metabolic health all influence how your body expresses risk over time.

This is where epigenetics becomes relevant.

C15:0 has entered longevity conversations because some research suggests it may affect pathways involved in nutrient sensing, inflammation, mitochondrial function, and cellular resilience. These pathways overlap with many of the biological systems involved in aging.

However, this does not mean C15:0 is proven to reverse biological age in humans.

A more accurate statement is that C15:0 is being studied for its potential role in cellular and metabolic pathways that may influence healthspan. That is promising, but it is not the same as proof that a supplement will make every woman biologically younger.

At My Venus Club™, this is why we do not guess. We use tools such as biological age testing, cardiometabolic testing, hormone evaluation, and inflammation markers to understand what is happening in the woman in front of us.

C15:0 Food Sources

C15:0 is found naturally in small amounts in whole-fat dairy and some animal-based foods.

Food sources may include whole milk, butter, full-fat yogurt, aged cheese, cream, ruminant fats, and some fish.

This does not mean every woman should increase dairy fat. Some women tolerate dairy well, while others experience bloating, acne, migraines, digestive symptoms, immune reactivity, or inflammation. Some women have lipid disorders, high ApoB, elevated LDL particle number, familial hypercholesterolemia, high triglycerides, or cardiovascular disease that requires a more cautious approach.

Food context matters. Plain full-fat yogurt is very different from ultra-processed dairy desserts. A small amount of grass-fed butter in a nutrient-dense diet is very different from a diet high in processed meats, refined carbohydrates, fried foods, and low fiber.

C15:0 should not become permission to overconsume saturated fat. It should become a reason to think more precisely about fats, foods, and personal risk.

C15:0 Supplementation

C15:0 supplements are now available, and this is where women need careful guidance.

Supplements are not regulated like prescription medications. They should not be marketed as cures for aging, heart disease, diabetes, liver disease, hormone imbalance, menopause symptoms, or inflammation.

Some research and commercial products use purified C15:0, and human supplementation research is beginning. However, optimal dosing, long-term safety, and which populations benefit most are not fully established.

Women should not assume that more is better. Anyone considering C15:0 should review health history, lipid markers, triglycerides, ApoB or LDL particle patterns, inflammatory markers, liver health, dairy tolerance, medications, pregnancy status, and overall goals with a qualified healthcare provider.

This is especially important for women with cardiovascular disease, very high triglycerides, familial hypercholesterolemia, liver disease, pregnancy, lactation, complex medication regimens, or a history of significant lipid disorders.

Who Might Consider Discussing C15:0?

C15:0 may be worth discussing for women who are navigating perimenopause, metabolic resistance, elevated inflammation, fatty acid imbalance, cardiometabolic risk factors, accelerated biological aging patterns, or interest in evidence-informed nutritional optimization.

It may be less relevant for women with excellent metabolic health, women who are looking for a quick fix, or women who expect one nutrient to replace foundational lifestyle changes.

C15:0 works best as part of a larger conversation about metabolic health, hormones, inflammation, cellular resilience, and long-term prevention.

What C15:0 Cannot Replace

C15:0 cannot replace exercise, sleep, strength training, blood sugar regulation, hormone evaluation, stress management, medical care, cardiology care when needed, or a thoughtful nutrition strategy.

This is the most important part of the conversation.

Women need muscle. They need stable blood sugar. They need restorative sleep. They need inflammation addressed. They need hormones evaluated in context. They need gut health supported. They need cardiovascular risk assessed properly. They need stress physiology taken seriously.

C15:0 may support the system, but it does not become the system.

The My Venus Club™ Framework

At My Venus Club™, we do not throw supplements at symptoms. We test, analyze, personalize, and monitor.

When we think about C15:0, we consider it in the context of three larger questions.

The first question is what is happening hormonally. DUTCH testing may help us evaluate cortisol patterns, estrogen metabolism, progesterone patterns, and stress-related hormone disruption.

The second question is what is happening biologically with aging. Epigenetic testing may help us understand biological age patterns, pace of aging, inflammatory aging signals, and methylation-related insights.

The third question is what is happening cardiometabolically. Boston Heart testing may help us evaluate insulin resistance, lipid patterns, small dense LDL, ApoB, inflammation markers, fatty acid balance, triglycerides, and other cardiovascular risk markers.

C15:0 is not a hormone. It is not a medication. It is not a cure. But for the right woman, in the right context, it may be a nutrient worth considering as part of a broader cellular and metabolic health strategy.

The Balanced Bottom Line

Here is the most responsible way to summarize C15:0.

C15:0 is an odd-chain saturated fatty acid found in certain foods, especially dairy fat, and higher circulating levels have been associated with better cardiometabolic outcomes in observational research.

Dr. Stephanie Venn-Watson’s research helped bring C15:0 into the healthspan conversation and suggests that it may influence pathways related to inflammation, AMPK, PPAR, mTOR, mitochondrial function, liver health, and cellular resilience.

What still needs more research is whether C15:0 supplementation produces meaningful long-term clinical benefits in diverse human populations, especially women in perimenopause and menopause.

What is not proven is that C15:0 reverses aging, prevents disease by itself, replaces medical care, or benefits every woman equally.

That is the balance women deserve: curiosity without hype, science without exaggeration, and personalization without guessing.

Start a Conversation About Your Healthspan

If you are tired of being told your labs are normal when you know something is off, it may be time for a deeper look.

If you are guessing which supplements or diets might actually work, it may be time for a more personalized approach.

If you are navigating perimenopause without a clear roadmap, it may be time to evaluate the full terrain: hormones, metabolism, inflammation, cardiometabolic health, gut health, cellular health, and biological aging.

At My Venus Club™, we do not wait for crisis. We help women understand their bodies earlier, so they can make informed decisions with clarity and confidence.

Apply to Join My Venus Club™

Apply for membership to start a discovery conversation and see whether the Venus Pathway™ is right for you.

Inside My Venus Club™, you receive comprehensive testing, personalized protocols, root-cause investigation, ongoing support, a team-based care model, and a community of empowered women.

You are not a generic protocol.

You deserve personalized care.

---

 

Go Deeper with The Ageless Woman

For more on inflammation, hormones, autoimmunity, and women's health:

Listen on your favorite platform:

• 🟣 https://music.amazon.com/podcasts/e4d24009-4c18-4bce-b0ed-b56fdc45e1bf/the-ageless-woman-podcast
• ⚪ https://open.spotify.com/show/385AV3IkcNY2HWThXdEd66?si=7c744f5f9a814181
• 🍎 https://podcasts.apple.com/us/podcast/the-ageless-woman-podcast/id1893647896

Read more on our blog: https://www.myvenusclub.com/blog

---

Summary: What We Know About C15:0

Well-Supported

• Lower diabetes risk associations
• Anti-inflammatory effects in vitro
• Mitochondrial support
• PPAR and AMPK activation
• Favorable cardiometabolic associations

Needs More Research

• Causal mechanisms in humans
• Optimal dosing for women
• Specific effects in perimenopause
• Long-term safety of high-dose supplementation
• Superiority over whole dairy

Not Yet Proven

• Use as a standalone therapy
• Replacement for established interventions
• Guaranteed anti-aging effects
• Universal benefit for every woman

---

A Note From Dr. Grow

I have spent over 25 years caring for women in family medicine, cardiac care, home health, and integrative settings.

I have seen what happens when women are told their labs are “normal” while their bodies scream otherwise.

C15:0 is not a cure-all.

But it is a remarkable example of how the right nutrient, at the right time, for the right woman can make a real difference.

If you are navigating perimenopause and wondering why your body feels different — why your energy, metabolism, and sense of self have shifted — you do not have to figure it out alone.

We test.
We analyze.
We personalize.
We walk with you.

With heart and care,
Dr. Cindy Grow, APRN

---

Medical Disclaimer

This article is for educational purposes only and does not replace medical advice.

Always consult with your healthcare provider before starting any new protocol.

Dr. Cindy Grow is a board-certified nurse practitioner specializing in functional medicine and women’s health.

References & Resources